Clinical trial · Interventional
Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical
Alleviating Androgen Deprivation Therapy (ADT) + External Beam Radiation (EBR) Treatment Side Effects in Prostate Cancer Patients
NCT06643494CI-TRIAL-00087013suspendedPhase 1 / Phase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PPI currently unable to continue.
Summary
Brief summary (as posted)
Does nutraceutical N-111 lower the number of side effects occurring during ADT + External Beam Radiation (EBR) prostate cancer treatment?
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| N-111 | Dietary Supplement | — | UNRESOLVED |
| Placebo | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- N-111
- description
- Nutraceutical N-111 in conjunction with ADT + EBR will be given in this arm, once per day with breakfast.
- interventionNames
- Dietary Supplement: N-111
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- A placebo that is inert but appears to look the same as the active comparator in conjunction with ADT + EBR, given once per day with breakfast.
- interventionNames
- Other: Placebo
- type
- NO_INTERVENTION
- label
- Control
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Male undergoing treatment for prostate cancer with ADT + EBR. Exclusion Criteria: * Everyone else
References
Publications (0)
Data not yet available
No reference posted for this study.